Showing results (281-290 of 332) with videos related to
Sort By:
Pageof 34
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2020
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MSMikael Cohen, Lydiane Mondot, Florence Bucciarelli, et al.Journal of the Neurological Sciences|March 23, 2016
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled studyLaure Peyro Saint Paul, Christian Creveuil, Olivier Heinzlef, et al.Neurology and Therapy|February 10, 2023
Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French CohortJuliette Pelle, Anais R Briant, Pierre Branger, et al.Journal of Autoimmunity|February 14, 2017
Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillanceLamiae Grimaldi-Bensouda, Michel Rossignol, Isabelle Koné-Paut, et al.Neurology(R) Neuroimmunology & Neuroinflammation|September 30, 2017
Radiologically isolated syndrome in children: Clinical and radiologic outcomesNaila Makhani, Christine Lebrun, Aksel Siva, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 11, 2019
CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERSGuillaume Taieb, Patricia Mulero, Dimitri Psimaras, et al.Neurology(R) Neuroimmunology & Neuroinflammation|June 16, 2021
Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating DiseasesKathrin Schanda, Patrick Peschl, Magdalena Lerch, et al.Annals of Neurology|September 22, 2020
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAlvaro Cobo-Calvo, Anne Ruiz, Fabien Rollot, et al.European Journal of Epidemiology|July 31, 2025
Methods of estimating prevalence of multiple sclerosis in six European healthcare data sources: a contribution from the ConcePTION projectMarie Beslay, Anna-Belle Beau, Davide Messina, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 23, 2023
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiersLars Forsberg, Tim Spelman, Pernilla Klyve, et al.Pageof 34